AAIC 2025 Abstract
APOE ε4 genotyping for populational enrichment of tau‐targeting clinical trials in cognitively impaired individuals
By Lucas Bastos Beltrami, João Pedro Ferrari-Souza, Laura Rosso, Show 17 more authorsEduardo Rigon Zimmer
Study in peopleBiomarkers
Abstract
Background: The accumulation of tau tangle deposits is a potential target for clinical trials in Alzheimer's disease (AD).
